Otsuka Holdings Co., Ltd.

4578.T
Drug Manufacturers - General
2026/09/01 Updated
Market Cap: $40.7B (¥6.5T)
Stock Price: $77.37 (¥12,360)
Exchange Rate: 1 USD = ¥159.74

Notice on the Status of Share Buyback

Acquisition of treasury stock through market purchases. Total amount: 5,597,125,500 yen; total shares: 465,800 shares; acquisition period: August 1–31, 2026; method: market purchase (Tokyo Stock Exchange).

Importance:
Page Updated: September 1, 2026
IR Disclosure Date: September 1, 2026

Key Figures

  • Total amount of acquisition value: 5,597,125,500 円
  • Total number of shares acquired: 465,800 株
  • Acquisition period: 2026 年8月1日〜2026 年8月 31 日

AI要約

Overview of the Share Buyback

We conducted market purchases of treasury stock in accordance with the provisions of Article 459, Paragraph 1 of the Companies Act, following a resolution by the Board of Directors. The acquisition target was common stock, and the upper limit of total shares and the acquisition period were disclosed in the previous resolution. This acquisition was carried out over the one-month period from August 1 to August 31, with a total acquisition value of approximately 559.7 million yen and total shares of 465,800.

Impact and Background

This matter was conducted as part of capital policy through the acquisition of treasury stock, positioned as a measure to mitigate dilution and enhance shareholder returns. The stated acquisition cap is the same as the total allowance indicated in the previous board resolution, and the cumulative acquisition status is described in the appendix. Future disclosure trends will be announced as additional acquisition status or changes to the acquisition period occur.

This page uses AI to summarize IR materials from TDnet. Please refer to the original document for investment decisions.

Otsuka Holdings Co., Ltd.

Company overview · Stock price · Financial data · All IR

View company page →